Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan-based conditioning for allogeneic hematopoietic stem cell transplantation in thalassemia major
2005-005913-40Phase 2Active
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Mar 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of treosulfan in beta thalassemia major, sponsored by IRCCS San Matteo Foundation. Primary endpoints: Rapid engraftment and Overall survival. Started Mar 2006; status: active.
02
Drugs
treosulfan
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on 2005-005913-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005913-40.